Jitai Technology has reached a cooperation agreement with Hengrui Medicine in the field of artificial intelligence formulation platforms.

On August 3, Jitai Technology announced on the Hong Kong Stock Exchange that its independently developed AiTEM artificial intelligence formulation innovation platform will be localized at Jiangsu Hengrui Medicine Co., Ltd., accelerating the efficiency of drug formulation development.